Impact of the change of copay policy in Medicare Part D on zoster vaccine uptake among Medicare beneficiaries in a managed care organization

被引:0
作者
Rulin C. Hechter
Lei Qian
Songkai Yan
Yi Luo
Girishanthy Krishnarajah
Hung-Fu Tseng
机构
[1] Kaiser Permanente Southern California,Department of Research & Evaluation
[2] GSK,US Health Outcomes & Epidemiology
[3] CSL Behring, Vaccines
来源
BMC Health Services Research | / 17卷
关键词
Zoster; Vaccination; Medicare; Part D; Copay;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 29 条
[1]  
Harpaz R(2008)Prevention of herpes zoster: recommendations of the advisory committee on immunization practices (ACIP) MMWR Recomm Rep 57 1-30
[2]  
Ortega-Sanchez IR(2011)Herpes zoster vaccination among adults aged 60 years and older, in the U.S., 2008 Am J Prev Med 40 e1-e6
[3]  
Seward JF(2014)Noninfluenza vaccination coverage among adults - United States, 2012 MMWR Morb Mortal Wkly Rep 63 95-102
[4]  
Lu PJ(2010)Barriers to the use of herpes zoster vaccine Ann Intern Med 152 555-560
[5]  
Euler GL(2009)Lower copay and oral administration: predictors of first-fill adherence to new asthma prescriptions Am Health Drug Benefits 2 174-180
[6]  
Harpaz R(2012)How patient cost-sharing trends affect adherence and outcomes: a literature review P T 37 45-55
[7]  
Williams WW(2014)Moving branded statins to lowest copay tier improves patient adherence J Manag Care Pharm 20 34-42
[8]  
Lu PJ(2008)Impact of decreasing copayments on medication adherence within a disease management environment Health Aff (Millwood) 27 103-112
[9]  
O'Halloran A(undefined)undefined undefined undefined undefined-undefined
[10]  
Hurley LP(undefined)undefined undefined undefined undefined-undefined